Emory University v Biochem Pharma Inc

Link copied
Case Copied 18 min read

OFFICIAL NOTICE

DECISION OF A DELEGATE OF THE COMMISSIONER OF PATENTS

Application  :          No. 658136 in the name of Emory University

Title:          Method and composition for the synthesis of BCH-189 and related compounds

Action:          Review of taxation of costs

Decision:          Issued

Abstract

The construction of Items 12-14, Part 1, Schedule 8 of the Regulations, which sets out costs which may be awarded pursuant to Paragraph 22.8 (2) (a) for proceedings before the Commissioner, was considered.

The word "or" as it is used in Items 12 and 13, Part 1, Schedule 8 of the regulations is used in a disjunctive sense, ie one thing or the other, but not both.  Any award of costs according to the Schedule only entitles the claiming of costs in relation to attendance at a hearing by either a patent attorney or a solicitor, not both.

Costs as per Item 14, Part 1 of Schedule 8 relate exclusively to attendance at a hearing by Counsel in the singular, not plural.

Any award of costs which varies from, or goes beyond, Schedule 8 is a matter for determination by the Commissioner, or her delegate, under regulation 22.8(1) in conjunction with the consideration of the matter which was in dispute.

The taxation of the Taxing Officer was altered and a new taxation of costs issued.

PATENTS ACT 1990

DECISION OF A DELEGATE OF THE COMMISSIONER OF PATENTS

Re:Patent Application No. 658136 by Emory University, and a review of taxation of costs in an opposition by Biochem Pharma Inc.

BACKGROUND

Emory University (Emory) is the applicant for patent application number 658136.  The grant of a patent for the application was opposed by Biochem Pharma Inc (Biochem) and a decision in relation to the opposition issued on 5 August 1999.

In the decision on the opposition the delegate awarded costs in accordance with Schedule 8 of the Regulations against Emory.

On 30 September 1999, Biochem submitted a claim for costs detailing a variety of items totalling $45,585, for taxation and certification by the Patent Office.  On 11 October 1999, Emory filed a written submission detailing their objections to the basis and extent of the costs claimed by Biochem.  On 21 October 1999, the Patent Office requested Biochem to provide details of the make up of the claim for transport costs.  Biochem, on 28 October 1999, provided further information in relation to travel costs as well as further submissions in relation to the overall award of costs.

On 3 November 1999, the Patent Office issued written advice to both parties advising that costs have been taxed at $15,450 and would be so allowed and certified at the expiration of 21 days.

Following a request by Biochem for a specific breakdown of costs, the Patent Office issued a letter, on 18 November 1999, informing both parties that the advice that costs had been taxed in the amount of $15,450, was in error.  The amount of costs taxed had been revised to $17,075 and in the absence of any request…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Emory University v Biochem Pharma Inc and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2000] APO 53
Decision Date

CaseChat Overview and Summary

In the case of Emory University v Biochem Pharma Inc, the court considered the construction of items 12-14, Part 1, Schedule 8 of the Regulations, which sets out costs that may be awarded in proceedings before the Commissioner of Patents. The dispute involved the interpretation of these items and whether they allowed for the claiming of costs for attendance at a hearing by both a patent attorney and a solicitor, or both senior and junior counsel. The court also considered whether expenses under Part 2 of Schedule 8 were specifically limited to "persons" for whom costs may be claimed under Part 1.

The court found that the word "or" as it is used in items 12 and 13 is used in a disjunctive sense, meaning one thing or the other, but not both. Thus, items 12 and 13 are restricted to claiming costs either in relation to attendance at the hearing by a patent attorney or a solicitor, and it does not extend to claiming costs for the appearance at a hearing for both a patent attorney and a solicitor. In terms of item 14, the court held that it refers to counsel fees for attendance at a hearing in the singular, not plural. Therefore, any claim for costs for both senior and junior counsel is a claim to a variation of costs over and above Schedule 8 and is not appropriate in an award of costs in accordance with the Schedule.

The court further held that expenses for a "person attending" a proceeding before the Commissioner under Paragraph 2, Division 1, Part 2 of Schedule 8 are limited to such person(s) whose attendance is in accordance with items 12-14 of Part 1 of Schedule 8. Given the court's conclusions above, the transport, accommodation and meal expenses are necessarily restricted to those of Haliday (Attorney) and Bennett (Senior Counsel) as they are the two persons for whom costs may be claimed under items 13 and 14, Part 1, Schedule 8 respectively.

The court concluded that the Taxing Officer was correct in the majority of the taxation of costs, but incorrect in the taxation of transport, accommodation and meal expenses. The opposition and hearing fees, which were not previously claimed, were allowable expenses. Therefore, the amount of allowable costs should be reduced by $2,550. Costs are allowed in the amount of $14,525, and a certificate of costs for that amount will now issue.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established